S&P 500   3,363.00 (+0.83%)
DOW   27,781.70 (+1.20%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
S&P 500   3,363.00 (+0.83%)
DOW   27,781.70 (+1.20%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
S&P 500   3,363.00 (+0.83%)
DOW   27,781.70 (+1.20%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
S&P 500   3,363.00 (+0.83%)
DOW   27,781.70 (+1.20%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
Log in
NASDAQ:STAA

STAAR Surgical Stock Forecast, Price & News

$56.56
+0.20 (+0.35 %)
(As of 09/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$55.50
Now: $56.56
$57.40
50-Day Range
$45.65
MA: $50.63
$56.36
52-Week Range
$23.20
Now: $56.56
$62.51
Volume391,229 shs
Average Volume573,167 shs
Market Capitalization$2.59 billion
P/E Ratio353.52
Dividend YieldN/A
Beta1.43
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Monrovia, California.
Read More
STAAR Surgical logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.48 out of 5 stars


Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:STAA
CUSIP85231230
Phone626-303-7902

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$150.18 million
Cash Flow$0.63 per share
Book Value$3.59 per share

Profitability

Net Income$14.05 million

Miscellaneous

Employees475
Market Cap$2.59 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$56.56
+0.20 (+0.35 %)
(As of 09/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

How has STAAR Surgical's stock been impacted by COVID-19?

STAAR Surgical's stock was trading at $28.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, STAA stock has increased by 101.9% and is now trading at $56.56.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of STAAR Surgical?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for STAAR Surgical
.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for STAAR Surgical
.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) posted its earnings results on Wednesday, August, 5th. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by $0.01. The medical instruments supplier had revenue of $35.19 million for the quarter, compared to the consensus estimate of $37.60 million. STAAR Surgical had a return on equity of 8.78% and a net margin of 5.03%. During the same period in the previous year, the firm posted $0.08 earnings per share.
View STAAR Surgical's earnings history
.

What price target have analysts set for STAA?

6 Wall Street analysts have issued 1-year price objectives for STAAR Surgical's shares. Their forecasts range from $41.00 to $70.00. On average, they anticipate STAAR Surgical's share price to reach $58.83 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price.
View analysts' price targets for STAAR Surgical
.

Are investors shorting STAAR Surgical?

STAAR Surgical saw a decline in short interest in the month of August. As of August 14th, there was short interest totaling 2,510,000 shares, a decline of 13.1% from the July 30th total of 2,890,000 shares. Based on an average trading volume of 738,100 shares, the short-interest ratio is presently 3.4 days.
View STAAR Surgical's Short Interest
.

Who are some of STAAR Surgical's key competitors?

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), Walt Disney (DIS), Paypal (PYPL), Shopify (SHOP), Crowdstrike (CRWD), Docusign (DOCU), Trade Desk (TTD), Roku (ROKU) and Teladoc Health (TDOC).

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the following people:
  • Ms. Caren L. Mason, CEO, Pres & Director (Age 65)
  • Ms. Deborah J. Andrews, Chief Financial Officer (Age 62)
  • Dr. Keith Holliday, Chief Technology Officer (Age 56)
  • Mr. Samuel J. Gesten, Chief Legal Officer & Corp. Sec. (Age 57)
  • Mr. Hans-Martin Blickensdoerfer, Sr. VP of Commercial Operations, Direct Markets- Europe & China (Age 54)

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $56.56.

How big of a company is STAAR Surgical?

STAAR Surgical has a market capitalization of $2.59 billion and generates $150.18 million in revenue each year. The medical instruments supplier earns $14.05 million in net income (profit) each year or $0.46 on an earnings per share basis. STAAR Surgical employs 475 workers across the globe.

What is STAAR Surgical's official website?

The official website for STAAR Surgical is www.staar.com.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]

This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.